The Impact of Alkermes Inspiration Grants
Rhea-AI Impact
Rhea-AI Sentiment
NORTHAMPTON, MA / ACCESSWIRE / June 7, 2023 / Alkermes
In 2021, the Alkermes Inspiration Grants program funded nonprofit programs providing support for patient communities in the areas of addiction, serious mental illness and cancer. Watch this video to hear grantees' perspectives about the impact of AIG.
View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com.
Contact Info:
Spokesperson: Alkermes
Website: https://www.3blmedia.com/profiles/alkermes
Email: info@3blmedia.com
SOURCE: Alkermes
View source version on accesswire.com:
https://www.accesswire.com/759887/The-Impact-of-Alkermes-Inspiration-Grants
Alkermes plc
NASDAQ:ALKS
ALKS Rankings
ALKS Latest News
ALKS Stock Data
4.13B
158.79M
1.25%
108.01%
8.58%
Pharmaceutical Preparation Manufacturing
Manufacturing
United States of America
DUBLIN 4
About ALKS
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.